Abbott Laboratories ABT
US equityMarket cap rank #93Medical DevicesBrain-Computer InterfaceInfectious DiseaseMpox (monkeypox)
$109.93 −$3.67 (-3.23%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $109.93 0.00%
Open$111.08
Prev close$113.60
Day range$109.81 – $111.81
Volume8.35M
Market cap$190.39B
P/E (TTM)40.9
Dividend yield2.26%
Analyst view
ConsensusBuy
Analysts17
Average target$122.40+11.3% vs. price
- Buy 94%
- Hold 6%
Low $115.00Now $109.93Avg $122.40High $135.00
Recent rating changes
The last 20 actions on file set price targets from $115.00 to $135.00, averaging $120.84.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 2 Nov 2026 | Piper Sandler | BUY | $118.00 |
| 30 Oct 2026 | BofA Securities | BUY | $115.00 |
| 26 Oct 2026 | Argus Research | HOLD | – |
| 23 Oct 2026 | Wells Fargo | BUY | $120.00 |
| 23 Oct 2026 | Evercore | BUY | $120.00 |
| 22 Oct 2026 | TD Cowen | BUY | $118.00 |
| 22 Oct 2026 | Wells Fargo | BUY | $120.00 |
| 22 Oct 2026 | Piper Sandler | BUY | $118.00 |
| 22 Oct 2026 | Baird | BUY | $123.00 |
| 22 Oct 2026 | Stifel | BUY | $120.00 |
| 22 Oct 2026 | Citi | BUY | $122.00 |
| 22 Oct 2026 | Barclays | BUY | $120.00 |
| 22 Oct 2026 | J.P. Morgan | BUY | $118.00 |
| 21 Oct 2026 | Wells Fargo | BUY | $119.00 |
| 21 Oct 2026 | BTIG | BUY | $125.00 |
| 21 Oct 2026 | BofA Securities | BUY | $115.00 |
| 21 Oct 2026 | Citi | BUY | $125.00 |
| 21 Oct 2026 | RBC Capital | BUY | $125.00 |
| 16 Oct 2026 | TD Cowen | BUY | $135.00 |
| 7 Oct 2026 | J.P. Morgan | BUY | $120.00 |
No comments yet — be the first to weigh in on ABT.
Sign in to join the discussion.